Article
EU regulator backs use of Merck's viral infection drug
Rating:
0.0
Views:
39
Likes:
1
Library:
1
Merck & Co said on Tuesday the European Union medicines regulator recommended a marketing authorisation for the company's drug Prevymis to prevent a type of infection in adult kidney transplant recipients at high risk.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value